Drug intelligence / Profile preview

Sigesbeckia pubescens Makino extract

Development stage
Unknown
Lead developer
Phynova
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Sigesbeckia pubescens Makino extract is derived from the aerial parts of the annual plant Sigesbeckia pubescens, a member of the Asteraceae family native to East Asia. It has a long history in traditional Chinese and Korean medicine for treating inflammatory conditions such as arthritis, rheumatic pain, backache, sciatica, hypertension, malaria, and neurasthenia[1][3][4][5]. The primary bioactive constituents include diterpenoids (notably kirenol derivatives), flavonoids, sesquiterpenoids, and triterpenoids[3]. Modern research demonstrates anti-inflammatory and analgesic effects through modulation of immune responses (cellular/humoral/nonspecific immunity) and cytokine production[1][3]. Mechanistically, it inhibits proinflammatory chemokine production by modulating the Janus kinase 2/signal transducer and activator of transcription proteins 1/3 (JAK2/STAT1/STAT3) pathway in skin cells[4][6], supporting its use for musculoskeletal diseases as well as atopic dermatitis. In the UK it is licensed as an over-the-counter herbal medicine for joint/muscle pain; in the US it is available as a dietary supplement for joint health[1].

Brand names
Phynova Joint and Muscle Pain Relief Tablets
Other names
Sigesbeckia pubescens extractSigesbeckia orientalis subsp. pubescens extractSt Paul’s wortXi Xian Caopig pungent weed
02

Targets

JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)STAT1 (Signal transducer and activator of transcription protein 1)

Beyond the preview

Go deeper on Sigesbeckia pubescens Makino extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sigesbeckia pubescens Makino extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call